The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - GlaxoSmithKline; Johnson & Johnson; Pfizer; Regeneron
LINKER-MM1 study: Linvoseltamab (REGN5458) in patients with relapsed/refractory multiple myeloma.
 
Hans C. Lee
Consulting or Advisory Role - Allogene Therapeutics; Bristol Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Karyopharm Therapeutics; Legend Biotech; Monte Rosa Therapeutics; Oncopeptides; Pfizer; Sanofi; Takeda
Research Funding - Amgen; Celgene; GlaxoSmithKline; Janssen; Regeneron; Takeda
 
Naresh Bumma
Consulting or Advisory Role - Janssen
Speakers' Bureau - Amgen; Sanofi
 
Joshua Ryan Richter
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Antengene; Celgene; Karyopharm Therapeutics; Oncopeptides; Sanofi; Secura Bio; Takeda; X4 Pharma
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Janssen
 
Madhav V. Dhodapkar
Consulting or Advisory Role - Janssen Oncology; lava therapeutics; Roche/Genentech
 
James E. Hoffman
Stock and Other Ownership Interests - syndax
Honoraria - Bristol-Myers Squibb/Celgene
 
Attaya Suvannasankha
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Regeneron; Sutro Biopharma
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Jeffrey A. Zonder
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Regeneron; Takeda
Research Funding - Bristol-Myers Squibb; Janssen
 
Mansi R. Shah
Consulting or Advisory Role - Janssen
Research Funding - Abbvie (Inst); Janssen (Inst); Regeneron (Inst)
 
Suzanne Lentzsch
Leadership - Caelum Biosciences
Stock and Other Ownership Interests - Caelum Biosciences
Consulting or Advisory Role - Adaptive Biotechnologies; BMS; GlaxoSmithKline; Janssen; Natera; Oncopeptides; Pfizer; Sanofi; Takeda
Speakers' Bureau - BioAscent; Clinical Care Options; PeerView; RedMedEd.com
Research Funding - Sanofi
Patents, Royalties, Other Intellectual Property - Patent 11-1F4 mAb for use in AL Amyloidosis
 
Joseph J. Maly
No Relationships to Disclose
 
Jing Christine Ye
Honoraria - BMS; Janssen Scientific Affairs
Consulting or Advisory Role - BMS; Janssen
Research Funding - Celgene (Inst); Genmab (Inst); GlaxoSmithKline (Inst); MingSight (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst)
 
Ka Lung Wu
No Relationships to Disclose
 
Michelle DeVeaux
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Dhruti Chokshi
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Anita Boyapati
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Anasuya Hazra
No Relationships to Disclose
 
Karen Rodriguez-Lorenc
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Glenn Scott Kroog
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Research Funding - Regeneron
Travel, Accommodations, Expenses - Regeneron
 
Yariv J. Houvras
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Sundar Jagannath
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Legend Biotech; Regeneron; Sanofi; Takeda
Travel, Accommodations, Expenses - Brystol-Myers Squibb; Janssen Biotech